Healthcare Economics
🇺🇸 FDAFDA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global pharmaceutical markets. NovaPharmaNews delivers expert analysis on healthcare economics, market access, and pricing strategies.
Showing 1–5 of 5 articles
Quick answer
NovaPharmaNews Healthcare Economics hub for FDA covers 5 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Eli Lilly's 340B Data Mandate: A New Tactic in Pharma's Discount Program Battle
ISPOR 2026: Cardiology Advances - Day 1 Roundup
US-Japan Healthcare Conference 2026: Day 1 Highlights
FDA Accelerated Approval Pathway: Impact on Oncology Market Access & Pricing in 2026
ISPOR 2026: HEOR Policy & Pharma Pricing in Focus
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.